Company Monitoring Page for Cel-Sci

latest headlines for company on cafepharma

Cel-Sci's Successful Safety Review Not Yet Factored Into Valuation
Seeking Alpha
Fri, 11/2/12 - 11:10 am
Tags:
Cel-Sci, Multikine
3 High Beta Liquid Small-Cap Biotechnology Stocks That Are Breaking Out
Seeking Alpha
Mon, 09/17/12 - 11:05 am
Tags:
Cel-Sci, InterMune, Savient
Cel-Sci Corp, Synergy Pharmaceuticals Stocks Rise: Investors Should Start Paying Attention
Seeking Alpha
Tue, 05/1/12 - 11:29 am
Tags:
Cel-Sci, Synergy Pharmaceuticals
Cel-Sci Offers Huge Potential Gains With Revolutionary Immunotherapy Anti-Cancer Drug
Seeking Alpha
Tue, 03/13/12 - 11:25 am
Tags:
Cel-Sci, Teva Pharmaceuticals, Multikine, head and neck cancer
In Spite Of Dendreon's Woes, Other Players In The Sector Are Starting To Roll
Seeking Alpha
Mon, 03/5/12 - 11:13 am
Tags:
Dendreon, Provenge, prostate cancer, Celldex, Agenus, Cel-Sci, ImmunoCellular
2 Biotechs On Teva's Radar Screen
Seeking Alpha
Mon, 02/6/12 - 11:21 am
Tags:
Teva Pharmaceuticals, Cel-Sci, Bristol-Myers Squibb, Prolor
Past Bouncers And Others Biotech Plays Ready To Move
Seeking Alpha
Thu, 01/26/12 - 02:15 pm
Tags:
Aeterna Zentaris, Affymax, Ampio, Bacterin International Holdings, GelTech, Cel-Sci, Ista, Inovio, Lpath, Nabi, Novavax, PharmAthene
CEL-SCI says Multikine Phase III trial launched in dozens of hospitals
The Fly on the Wall
Mon, 01/23/12 - 11:25 am
Tags:
Cel-Sci, Multikine, head and neck cancer
CEL-SCI Corporation Releases Letter to Shareholders
Yahoo/BusinessWire
Sat, 01/21/12 - 01:08 pm
Tags:
Cel-Sci, Multikine, head and neck cancer
Biopharma Stocks To Watch This Week
Seeking Alpha
Thu, 01/19/12 - 11:12 am
Tags:
BioDelivery Sciences, Biovest International, Celldex, MannKind, NovaBay Pharmaceuticals, Keryx, ImmunoCellular, Cel-Sci, Dendreon, Generex, Human Genome Sciences
11 Biotech Bets For 2012
Seeking Alpha
Thu, 01/12/12 - 10:16 pm
Tags:
Zalicus, Teva Pharmaceuticals, Spectrum, Astex, Aeterna Zentaris, Cel-Sci, Dendreon, Keryx, NPS Pharmaceuticals, Pharmacyclics, Questcor
Dendreon Leads the 'Now Generation' For Cancer Immunotherapeutic Treatment
Seeking Alpha
Mon, 07/4/11 - 09:20 am
Tags:
Dendreon, prostate cancer, cancer immunotherapy, Cel-Sci, Cell Therapeutics, ImmunoCellular, Keryx, Teva Pharmaceuticals, Oncothyreon
Biotech Data Mining Comes Up Empty
TheStreet.com
Wed, 06/29/11 - 10:26 am
Tags:
data mining, Cel-Sci, Apricus Biosciences, Osiris, Transdel, Agenus, Introgen, Cell Therapeutics
Biotech Clinical Trials Update for 3 Drug Manufacturers
Seeking Alpha
Mon, 06/27/11 - 05:44 pm
Tags:
Pfizer, Cel-Sci, Bristol-Myers Squibb, Eliquis, Multikine
Cel-Sci: The Multikine Sweet 16
TheStreet.com
Tue, 05/3/11 - 02:36 pm
Tags:
Cel-Sci, Multikine
CEL-SCI gets Israeli nod to commence phase III trial of multikine in head and neck cancer
pharmabiz
Sat, 04/2/11 - 11:15 am
Tags:
Cel-Sci, Multikine, head and neck cancer
Biotech Stock Mailbag: Bio-Hazards
The Street
Sat, 03/26/11 - 10:00 am
Tags:
Telik, Xoma, Genta, Cell Therapeutics, Discovery Labs, Cel-Sci
Biotech Stock Mailbag: Orexigen Therapeutics
TheStreet.com
Fri, 01/28/11 - 12:13 pm
Tags:
Orexigen, Contrave, Arena Pharmaceuticals, Vivus, Avanir, Discovery Labs, Cel-Sci
CEL-SCI Investors Cheer a Bit Too Loudly
Motley Fool
Fri, 12/31/10 - 11:27 am
Tags:
Cel-Sci, Multikine, head and neck cancer
Cel-Sci cuts losses, R&D triples
Bizjournals.com
Tue, 05/18/10 - 09:55 am
Tags:
R&D, Cel-Sci, earnings

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.